The targeted MS approach allowed us to establish the first global picture of S100 protein expression in the three most common tumours of the thyroid gland: follicular adenoma (FA), follicular thyroid carcinoma (FTC) and papillary thyroid carcinoma (PTC). Here, S100A1 is linked to thyroid tumor.